Shinobi Therapeutics, the biotechnology company developing a new class of immune evasive iPS therapies, today announced the appointment of Laurent Fischer, MD, as its first independent Chair of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback